PFIZER+ Trademark

Trademark Overview


On Tuesday, October 31, 2023, a trademark application was filed for PFIZER+ with the United States Patent and Trademark Office. The USPTO has given the PFIZER+ trademark a serial number of 98247942. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, October 16, 2024. This trademark is owned by Pfizer Inc.. The PFIZER+ trademark is filed in the Pharmaceutical Products category with the following description:

A full line of over the counter medicated preparations for use in the treatment of cold and flu, pain, allergy, gastrointestinal and respiratory disorders and a full line of pharmaceutical preparations for use in connection with humans; pharmaceutical preparations for the treatment of respiratory, infectious and viral diseases and disorders; cough suppressant in the nature of cough syrups, cough drops, and anti-cough drops; cold medicines in the nature of preparations for treating colds; cold and sinus medicines in the nature of pharmaceutical preparations for the treatment of sinus congestion; analgesic preparations; dietary and nutritional supplements; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Covid-19, Influenza A, Influenza B and Respiratory Syncytial virus
pfizer+

General Information


Serial Number98247942
Word MarkPFIZER+
Filing DateTuesday, October 31, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements


Goods and ServicesA full line of over the counter medicated preparations for use in the treatment of cold and flu, pain, allergy, gastrointestinal and respiratory disorders and a full line of pharmaceutical preparations for use in connection with humans; pharmaceutical preparations for the treatment of respiratory, infectious and viral diseases and disorders; cough suppressant in the nature of cough syrups, cough drops, and anti-cough drops; cold medicines in the nature of preparations for treating colds; cold and sinus medicines in the nature of pharmaceutical preparations for the treatment of sinus congestion; analgesic preparations; dietary and nutritional supplements; Diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Covid-19, Influenza A, Influenza B and Respiratory Syncytial virus
Pseudo MarkPFIZER PLUS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2024ASSIGNED TO EXAMINER
Wednesday, July 17, 2024NON-FINAL ACTION WRITTEN
Friday, November 3, 2023NEW APPLICATION ENTERED
Wednesday, July 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 24, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED